The key to the approach lies in a piece of physics that dates back to 1976, when Robert Alvarez and Albert Macovski showed that X-ray attenuation in the diagnostic energy range can be described as the sum of just two effects: the photoelectric effect and Compton scattering. The photoelectric contribution depends strongly on the atomic number of the material, while the Compton contribution depends mainly on electron density. If attenuation can be measured at several different X-ray energies, the two contributions can be mathematically separated, and from them the material’s mass density and its effective atomic number — a weighted average of the atomic numbers of the elements it contains — can be calculated. This formalism underlies virtually every spectral CT technique in use today, from virtual non-contrast imaging to material decomposition.

What has historically made such calculations difficult in the clinic is that the raw projection data needed for them are locked away inside proprietary scanner software. Manufacturers guard the sinograms, the scanner geometry, the beam-hardening corrections and the spectral detector response functions that a from-scratch reconstruction would require. The German team sidestepped this obstacle elegantly: instead of raw data, they used virtual monoenergetic images, or VMIs, which the scanner’s own software already produces. VMIs simulate what a CT image would look like if the X-ray beam consisted of photons at a single energy, and because the manufacturer has already corrected them for beam hardening, beam quality and detector efficiency, they arrive ready for quantitative analysis. No knowledge of the bow-tie filter or the tube spectrum is needed.

The scanner in question was the Naeotom Alpha from Siemens Healthineers, the first clinically approved photon-counting CT system, released in 2021. Unlike conventional detectors that merely count photons in aggregate, photon-counting detectors register each X-ray photon individually and sort them by energy, providing spectral data intrinsically with every scan and without any additional radiation dose to the patient. From a single acquisition, the researchers generated virtual monoenergetic reconstructions at six energies — 40, 50, 60, 80, 100 and 150 kiloelectronvolts — using the scanner’s Syngo.Via software, and then imported these image sets into their own Python-based analysis pipeline.

The mathematics at the heart of the method is disarmingly compact. Following the Alvarez-Macovski model, the linear attenuation coefficient at each energy is written as a photoelectric term, scaling with density, effective atomic number and an inverse power of the energy, plus a Compton term described by the Klein-Nishina function. Substituting two composite coefficients reduces the problem to a linear system: with attenuation measured at two or more energies, the coefficients can be solved by linear regression, and from them density and effective atomic number follow directly. Using six energies rather than the minimum of two gives the regression extra robustness against the noise that inevitably contaminates real CT data, producing more stable values in the final maps.

Before the algorithm could touch a scanner, its four free parameters had to be calibrated. The team fitted the model to reference attenuation data from the NIST XCOM database for sixteen elements spanning effective atomic numbers from 5, boron, to 20, calcium — precisely the range occupied by the elements that make up human tissue, and a range conveniently free of the abrupt K-edge absorption features that would complicate the fit. The calibration, performed over 40 to 200 keV, yielded parameters remarkably close to those reported by earlier groups, with a coefficient of determination of 0.9996. A verification step then confirmed that the calibrated model reproduces the literature values for density and atomic number with slopes of almost exactly one, small residual deviations being folded in as correction factors.

To test the method on real scanner output, the researchers prepared a series of alcohol-water mixtures — ethanol at 0, 25, 50, 75 and 95 percent by volume, and isopropanol at 0, 10, 35, 60 and 70 percent. These humble mixtures were chosen deliberately: their densities and effective atomic numbers fall squarely in the soft-tissue range of the human body, they are cheap, safe and easy to prepare, and their expected properties can be calculated from published reference data. The tubes were mounted in a custom epoxy-resin phantom nested inside a larger PMMA ring to mimic the scattering conditions of a human torso, and scanned five times at 140 kilovolts so that image noise could be reduced by averaging.

The results were strikingly accurate. Across both mixture series, the measured mass densities deviated from the expected values by an average of just 1.0 percent, while the effective atomic numbers deviated by 0.84 percent. Pure water yielded an effective atomic number of 7.49 against an expected 7.47, and even the most concentrated alcohol solutions tracked their reference values almost perfectly. The maps themselves visually distinguished every concentration in both series. The accuracy is comparable to that reported by earlier image-domain approaches, such as the work of Heismann and colleagues, which required far more complex preprocessing of raw data to achieve deviations of similar magnitude.

The method is not without limits. The Zeff maps proved noisier than the density maps, because Compton scattering depends only weakly on attenuation in this energy range, leaving the atomic-number estimate more vulnerable to image noise, and residual beam-hardening effects produced a gentle gradient across the phantom. The algorithm is also valid only for materials with effective atomic numbers between 5 and 20 and densities up to about 2.0 grams per cubic centimeter — a range that comfortably covers biological tissue, including cortical bone at roughly 1.8 to 2.0, but excludes denser materials such as metal implants. Strong artifacts that distort Hounsfield units, such as severe beam hardening, will propagate into erroneous map values, since the entire method rests on the fidelity of the underlying image data.

Even so, the study lands at a moment of rapid momentum in quantitative spectral imaging. Recent work by Zimmerman and Poludniowski and by Lustermans and colleagues has demonstrated photon-counting CT’s potential for radiotherapy-related material characterization, while other groups are pursuing physics-informed deep-learning approaches to the same problem. Against those data-hungry machine-learning methods, the new algorithm offers a complementary virtue: it is analytically derived, transparently calibrated against tabulated reference data, computationally light, and runs entirely on image data that any clinical workstation can export. The authors suggest it could support applications from radiation therapy planning, where density and atomic number inform dose calculations, to oncology, where tissue characterization may distinguish tumor from benign lesions, or the identification of uric acid stones. Future studies, they note, must validate the approach across different phantoms, protocols, dose levels and realistic tissue compositions — but the demonstration that hospital-ready images alone can yield quantitative chemical maps marks a meaningful step toward making spectral material analysis a routine part of clinical CT.

Subject of Research: Calculation of mass density and effective atomic number maps from virtual monoenergetic photon-counting CT images

Article Title: Computation of the effective atomic number and mass density from virtual monoenergetic photon-counting CT reconstructions

Article References: Horstmeier, S., Thomsen, F. S., & Borggrefe, J. (2026). Computation of the effective atomic number and mass density from virtual monoenergetic photon-counting CT reconstructions. Heliyon, 12(14), Article e45404. https://doi.org/10.1016/j.heliyon.2026.e45404

Image Credits: AI Generated

DOI: Not provided

Keywords: photon-counting CT, effective atomic number, mass density, virtual monoenergetic imaging, spectral CT, Alvarez-Macovski model, material decomposition, radiation therapy, tissue characterization, Heliyon, X-ray attenuation, quantitative imaging

Lung cancer remains the leading cause of cancer-related mortality worldwide, responsible for an estimated 18.7% of all cancer deaths. Due to its high fatality rate, timely and accurate imaging is critical for diagnosis, staging, and monitoring therapeutic response. Traditionally, CT imaging has been a cornerstone in lung cancer evaluation. However, conventional CT methods average incoming X-ray photons, which can limit resolution and contrast detail. In contrast, photon-counting CT directly counts individual photons and measures their energy, yielding images of exceptional sharpness and enhanced tissue characterization.

This technological leap allows for ultra-high resolution imaging with improved differentiation between tumor tissues and normal anatomy. The study’s lead author, Dr. Songwei Yue, a chief physician and professor at The First Affiliated Hospital of Zhengzhou University in China, emphasized the clinical significance of this advance. He stated that improved imaging not only facilitates early and accurate detection of recurrence—which occurs in 60 to 100% of lung cancer cases—but also enhances overall patient survival by guiding more effective treatment plans.

Addressing a critical challenge, the research team underscored the importance of minimizing patient exposure to ionizing radiation and contrast agents, both of which pose risks such as radiation-induced damage and contrast-induced acute kidney injury. These risks are compounded by the frequency of imaging needed for lung cancer follow-up. Although reducing radiation dose has traditionally risked compromising diagnostic accuracy, PCCT offers a solution by providing superior image quality even with substantially reduced radiation levels.

The study meticulously compared contrast-enhanced chest CT images from two evenly matched cohorts of 100 patients each. One group underwent ultra-high resolution photon-counting CT scaled to low radiation doses, while the other received conventional CT scans. Subgroup analyses considered variables like lesion size, categorized as smaller than or equal to 3 cm and larger than 3 cm, along with patient body mass index (BMI), reflecting a broad cross-section of clinical scenarios.

Quantitative and qualitative assessments were performed by experienced chest radiologists using standardized scoring systems evaluating noise levels, anatomical clarity, lesion sharpness, and visualization of intra-lesion structures. Remarkably, photon-counting CT reduced radiation exposure by over 66% and iodine contrast usage by more than 26% compared to conventional scans. These reductions translated into noticeably fewer adverse reactions, including a decreased incidence of acute kidney injury following contrast administration.

The enhanced visualization capabilities of photon-counting CT were particularly evident at a thin 0.4 mm section thickness, where images revealed greater detail and demarcation of necrotic tumor regions, particularly in smaller lesions. Conversely, for larger tumors exceeding 3 cm, slightly thicker sections provided optimal contrast and clarity, aiding precise quantification of necrotic versus viable tissue—information critical for therapeutic decision-making.

The technical superiority of PCCT also manifested in improved detection of malignant features associated with tumor enhancement patterns. Such features are vital for differentiating aggressive cancer subtypes and tailoring personalized treatment strategies. The study demonstrated that this increased diagnostic confidence was uniformly maintained across diverse patient BMIs and tumor sizes, underscoring PCCT’s versatility and robustness in clinical practice.

The implications extend beyond immediate diagnostic improvements. The data suggest that integrating PCCT into routine clinical workflows could revolutionize lung cancer surveillance protocols, minimizing cumulative radiation risks while maximizing the accuracy of tumor assessments. Consequently, this could lead to earlier intervention at relapse and improved longitudinal patient outcomes.

Looking forward, Dr. Yue and colleagues emphasize the need for longitudinal studies to evaluate photon-counting CT’s performance over extended follow-up periods within the same patient cohorts. Such investigations would clarify its utility in monitoring tumor progression, response to therapies, and potential for guiding adaptive treatment strategies in real time.

With its unprecedented combination of dose reduction, image quality enhancement, and improved diagnostic confidence, photon-counting CT represents a paradigm shift in thoracic oncology imaging. As Dr. Yue remarked, the technology is poised to replace conventional CT scanning methods in the near future, reshaping lung cancer diagnostics and potentially saving countless lives through superior imaging precision.

This transformative advancement underscores the continual evolution of medical imaging technology and illustrates how precision engineering can directly impact clinical outcomes. It serves as a beacon of hope for patients, clinicians, and radiology specialists striving for optimal cancer care in an increasingly complex healthcare landscape.

Subject of Research: People
Article Title: Photon-counting CT versus Energy-integrating Detector CT Performance for Various BMI and Tumor Sizes in Lung Cancer
News Publication Date: Not specified in the content
Web References: https://pubs.rsna.org/journal/radiology, https://www.rsna.org/, http://www.radiologyinfo.org
Image Credits: Radiological Society of North America (RSNA)
Keywords: Lung cancer, Medical imaging, Radiology

Rib fractures, often subtle and complicated by decomposition or positioning artifacts, present a persistent challenge in medicolegal investigations. Determining the presence and pattern of such fractures can be pivotal in reconstructing injury mechanisms, clarifying circumstances surrounding death, and distinguishing between accidental trauma and foul play. Conventional computed tomography (CT) systems, while useful, frequently fall short in resolving fine osseous details post-mortem. However, PCCT leverages advanced photon-counting detectors that differ fundamentally from energy-integrating detectors used in standard CT, enabling enhanced spatial resolution and spectral imaging capabilities that prove crucial for delicate fracture detection.

At its core, PCCT represents a paradigm shift by directly counting incoming X-ray photons and categorizing them by energy level, versus traditional CT’s analog integration of all detected photons. This energy discrimination facilitates material decomposition and enhances image contrast at a microscopic scale. In the forensic context, such detailed imaging allows precise differentiation between bone, true fractures, and postmortem artifacts such as drying cracks or postmortem damage, which can otherwise mimic traumatic injury in conventional imaging. The study spearheaded by Lombardo, Hartmann, Fridle, and colleagues delves deeply into these technical advantages, offering compelling evidence of PCCT’s superior diagnostic yields.

The research undertook methodical comparisons between standard post-mortem CT scans and photon-counting CT acquisitions across a robust sample population, capturing a spectrum of trauma severities and post-mortem intervals. By meticulously correlating imaging findings with autopsy results, the investigators quantitatively analyzed sensitivity, specificity, and overall diagnostic accuracy metrics. The results unequivocally favored PCCT, which demonstrated substantially heightened sensitivity for detecting subtle cortical disruptions in ribs, many of which were missed or ambiguously interpreted on conventional CT. This validation against the autopsy gold standard underscores PCCT’s potential to refine medicolegal evidence with scientific rigor.

Beyond raw detection capabilities, PCCT also enhances image reconstruction algorithms, enabling three-dimensional volumetric analyses of fracture morphology. Such dimensions provide forensic experts with enriched contextual data, including fracture displacement, comminution, and precise anatomic localization. This comprehensive visualization enables nuanced interpretations of injury mechanisms, aiding in differentiations between blunt force trauma, postmortem artifact, and incidental skeletal conditions. The ability to integrate parametric spectral data into advanced reconstructions is an innovation unique to PCCT, offering forensic practitioners a richer diagnostic palette than ever before.

Moreover, the photon-counting mechanism inherently reduces radiation dose requirements while maintaining or improving image quality. In post-mortem imaging, where radiation exposure concerns are less restrictive than live patient scanning, this dose efficiency translates to the feasibility of high-resolution scans without prolonged acquisition times or artifact compromises. Consequently, forensic facilities can incorporate PCCT protocols into routine workflows without significant operational constraints, increasing throughput and ensuring timely medico-legal assessments critical in judicial contexts.

The study’s implications extend into forensic education and multidisciplinary collaborations. Radiologists, forensic pathologists, and imaging technologists must be trained to interpret PCCT’s nuanced outputs and spectral imaging signatures accurately. The team’s comprehensive approach includes proposed guidelines for image acquisition parameters and interpretation criteria tailored specifically for post-mortem rib assessment. Such standardization efforts are vital for harmonizing practices across forensic centers globally, facilitating consistent case comparisons and bolstering expert witness testimony reliability in legal proceedings.

Interestingly, PCCT’s advanced spectral imaging capabilities also open avenues for post-mortem tissue characterization beyond bone. While this study centers on rib fractures, the technology’s potential for soft tissue differentiation, hemorrhage visualization, and foreign body identification foreshadows a broader forensic imaging revolution. Future research may harness PCCT’s multienergy data to non-invasively explore molecular and compositional changes in tissues related to trauma, disease, or decomposition, offering deeper insights that were previously inaccessible or required invasive autopsy.

The forensic community’s response to PCCT’s emergence has been enthusiastic, recognizing its potential to overcome longstanding challenges inherent in post-mortem imaging. By bridging the gap between radiological resolution and pathological confirmation, photon-counting CT refines cause-of-death determinations and injury reconstructions with unprecedented clarity. The technique’s applicability spans homicide investigations, accident analyses, and even mass disaster victim identification, where rapid, accurate skeletal assessments can significantly influence case outcomes.

However, transitioning from pioneering research to widespread adoption entails logistical considerations. High costs of PCCT instrumentation, need for specialized software, and initial training investments must be balanced against clinical and forensic utility gains. Collaborative networks and shared facility models may help mitigate these barriers, promoting equitable access to this powerful technology. Additionally, integrating PCCT findings into multidisciplinary forensic reports requires clear communication frameworks that translate complex spectral data into actionable medico-legal conclusions comprehensible to non-specialist stakeholders, including law enforcement and juries.

In the broader scientific landscape, this breakthrough aligns with the growing trend toward precision imaging and personalized diagnostics. Just as photon-counting CT is transforming clinical radiology by improving cancer detection and cardiovascular imaging, its forensic applications underscore how technology originally conceived for medical benefit can yield profound societal impacts in justice and public safety. Lombardo and colleagues’ work exemplifies the trailblazing synergy between engineering innovation and applied forensic science, illustrating a vibrant future for imaging-enabled truth-seeking.

Ultimately, photon-counting CT’s introduction into post-mortem forensic practice heralds an era where accurate, non-destructive rib fracture detection and skeletal trauma mapping become routine rather than exceptional. This leap forward promises to elevate autopsy standards, reduce diagnostic uncertainty, and strengthen the evidentiary foundation of medico-legal investigations worldwide. The ripple effects extend beyond technical improvements; they pave the way for ethical, transparent, and scientifically robust death investigations that uphold justice and honor the dignity of the deceased.

As forensic imaging continues to evolve, the integration of photon-counting CT will likely inspire further technological innovations, including artificial intelligence-assisted image interpretation, automated fracture detection algorithms, and multi-modal forensic datasets that fuse anatomical, biochemical, and spectral information. Each of these advancements, rooted in the diagnostic breakthroughs demonstrated by Lombardo, Hartmann, Fridle, and their team, brings the forensic sciences closer to a future where truth is uncovered with unparalleled precision, speed, and confidence.

The study’s findings ripple through not only forensic medicine but also forensic anthropology, radiology, and pathology disciplines, emphasizing multidisciplinary collaboration as critical to fully harnessing photon-counting CT’s promise. As institutions worldwide consider the next generation of forensic imaging workflows, this technology’s robust performance in rib fracture detection underscores its role as a cornerstone innovation, redefining what is possible at the intersection of technology and justice.

In conclusion, the application of photon-counting computed tomography to forensic post-mortem rib fracture detection marks a pivotal advancement in forensic imaging science. Lombardo et al.’s rigorous research delineates a clear pathway from innovative imaging physics to impactful forensic practice. This new modality offers a potent combination of enhanced diagnostic accuracy, improved artifact differentiation, dose efficiency, and rich spectral data that collectively transform the landscape of post-mortem examinations. Its adoption promises to enhance the evidentiary value of forensic investigations, safeguard judicial processes, and ultimately contribute to the pursuit of truth through science.

Article Title:
Diagnostic accuracy of rib fracture detection in forensic post-mortem photon counting CT

Article References:

Lombardo, P., Hartmann, C., Fridle, C. et al. Diagnostic accuracy of rib fracture detection in forensic post-mortem photon counting CT. Int J Legal Med (2025). https://doi.org/10.1007/s00414-025-03597-w

Image Credits: AI Generated